MedTrace Logo

Effect and Associated Factors of the Clinical Pharmacy Model in the Incidence of Medical Errors

NCT03338725 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 720

Last updated 2020-11-12

No results posted yet for this study

Summary

Medication errors are considered by WHO to be a subject that requires attention at all levels of care, in order to reduce the serious and preventable damage related to medication.

These strategies are aimed at the patient's safety policy. In Colombia, at the regulatory level there is no standardized clinical pharmacy model where the role of the clinical pharmacist is described extensively and in detail, and in addition, data are unknown of the scope or direct effect of the incorporation of this model in the assistance in the results of health care.

The Hospital Pablo Tobón Uribe, it is a highly complex institution in Medellin (Colombia), certified by Join Comission International (JCI), which requires the continuous interaction of the pharmacist in patient care, in order to avoid medication errors and contribute to patient safety indicators. In this sense, the hospital structured and implemented a clinical pharmacy model that establishes the activities of the pharmacist incorporated into the care team in the patient attention. Today this model is applied in the institution, however, it is necessary to know the effect of its application in the solution of drug-related problems (DRPs) or a negative outcome related to medicine. The objective of this study is to know the effect on patient safety of a clinical pharmacy model in a hospital of high complexity and framed in the WHO initiative to reduce these errors of medication.

Conditions

  • Pharmaceutical Services
  • Medication Errors
  • Drug-Related Side Effects and Adverse Reactions
  • Outcome Assessment (Health Care)

Interventions

OTHER

Clinical pharmacy model

Patients who are being monitored by a clinical pharmacy model

Sponsors & Collaborators

  • Hospital Pablo Tobón Uribe

    collaborator OTHER

  • Universidad de Antioquia

    lead OTHER

Principal Investigators

  • Johann Granados, Msc · Hospital Pablo Tobon Uribe

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
SEQUENTIAL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-01
Primary Completion
2019-05-30
Completion
2020-11-10

Countries

  • Colombia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03338725 on ClinicalTrials.gov